National Guideline Clearinghouse | Guidelines by Topic: Breast Neoplasms [1/4]

National Guideline Clearinghouse | Guidelines by Topic: Breast Neoplasms

Guidelines by Topic

Disease/Condition > Diseases (2488) > Neoplasms (653) > Neoplasms by Site (502) >

Breast Neoplasms (80)

Narrow:

Breast Neoplasms, Male (7)
Carcinoma, Ductal, Breast (2)
Hereditary Breast and Ovarian Cancer Syndrome (1)

Search WithinSearch within:    Go

Sort results by:  Relevance (what's this?)    Publication date

Filter results by:   All Years  2014  2013  2012  2011  2010  2009  2008  2007  2006  2005  2004  2003  2002  2001  2000  1999  1998  1997 

1-20 of 80   Next >
1.   Society of Surgical Oncology–American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. 2014 Mar 1. NGC:010420 American Society for Radiation Oncology - Professional Association; Society of Surgical Oncology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
2.   ACR Appropriateness Criteria® stage I breast cancer: initial workup and surveillance for local recurrence and distant metastases in asymptomatic women. 1996 (revised 2014). NGC:010443 American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
3.   Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement. 1996 (revised 2014 Feb 18). NGC:010191 U.S. Preventive Services Task Force - Independent Expert Panel. View all guidelines by the developer(s) Compare Selected
4.   Comparison of Oncotype DX with multi-gene profiling assays (e.g., MammaPrint, PAM50) and other tests (e.g., Adjuvant! Online, Ki-67 and IHC4) in early-stage breast cancer. 2013 Nov 20. NGC:010222 Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
5.   Medications for risk reduction of primary breast cancer in women: U.S. Preventive Services Task Force recommendation statement. 2002 Jul (revised 2013 Nov 19). NGC:010056 U.S. Preventive Services Task Force - Independent Expert Panel. View all guidelines by the developer(s)  Compare Selected
6.   Preventive services for adults. 1995 Jun (revised 2013 Sep). NGC:010043 Institute for Clinical Systems Improvement - Nonprofit Organization. View all guidelines by the developer(s) Compare Selected
7.   Treatment of primary breast cancer. A national clinical guideline. 1998 Oct (revised 2013 Sep). NGC:010022 Scottish Intercollegiate Guidelines Network - National Government Agency [Non-U.S.]. View all guidelines by thedeveloper(s) Compare Selected
8.   Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline. 1999 (revised 2013 Aug). NGC:009980 American Society of Clinical Oncology - Medical Specialty Society. View all guidelines by the developer(s)  Compare Selected
9.   Everolimus in combination with exemestane for treating advanced HER2-negative hormone-receptor-positive breast cancer after endocrine therapy. 2013 Aug. NGC:010011 National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
10.   Common breast problems. 2007 Oct (revised 2013 Jun). NGC:009958 University of Michigan Health System - Academic Institution. View all guidelines by the developer(s) Compare Selected
11.   Familial breast cancer: classification and care of people at risk of familial breast cancer and management of breast cancer and related risks in people with a family history of breast cancer. 2004 May (revised 2013 Jun). NGC:009952 National Collaborating Centre for Cancer - National Government Agency [Non-U.S.]. View all guidelines by thedeveloper(s) Compare Selected
12.   NSGC practice guideline: risk assessment and genetic counseling for hereditary breast and ovarian cancer.2007 Jun (revised 2013 Apr). NGC:009736 National Society of Genetic Counselors - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
13.   Adult preventive services (ages 18-49). 2005 Jul (revised 2013 Mar). NGC:009928 Michigan Quality Improvement Consortium - Professional Association. View all guidelines by the developer(s) Compare Selected
14.   Adult preventive services (ages 50 - 65+). 2005 Jul (revised 2013 Mar). NGC:009929 Michigan Quality Improvement Consortium - Professional Association. View all guidelines by the developer(s) Compare Selected
15.   Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. 1997 May (revised 2013 Mar 1). NGC:009457 American Society of Clinical Oncology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
16.   Evidence-based clinical practice guideline: breast reconstruction with expanders and implants. 2013 Mar. NGC:009869 American Society of Plastic Surgeons - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
17.   ACR Appropriateness Criteria® local-regional recurrence (LRR) and salvage surgery—breast cancer. 1996 (revised 2013). NGC:010174 American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
18.   Denosumab for the prevention of skeletal-related events in adults with bone metastases from solid tumours. 2012 Oct. NGC:009376 National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
19.   Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer.2012 Aug. NGC:009311 National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
20.   Sentinel lymph node biopsy and axillary node dissection in early stage breast cancer. 2012 Aug. NGC:009391 CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
1-20 of 80   Next >